Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICI) have revolutionized the treatment of hepatocellular carcinoma (HCC). In addition to their role in advanced HCC, there is considerable interest in using ICIs in the neoadjuvant setting, either as a downstaging or bridging therapy, prior to potentiall...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Qimeng, Anwar, Imran J., Abraham, Nader, Barbas, Andrew S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699137/
https://www.ncbi.nlm.nih.gov/pubmed/34944927
http://dx.doi.org/10.3390/cancers13246307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699137/
https://www.ncbi.nlm.nih.gov/pubmed/34944927
http://dx.doi.org/10.3390/cancers13246307

Ejemplares similares